Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modification of post-PKS tailoring steps through combinatorial biosynthesis.

Uwe Rix1, Carsten Fischer, Lily L Remsing

  • 1Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington 40536-0082, USA.

Natural Product Reports
|November 15, 2002
PubMed
Summary

Combinatorial biosynthesis enhances the engineering of post-polyketide synthase modifying enzymes. This review highlights key enzymes like oxygenases and transferases, crucial for natural product drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

Cancer research communications·2026
Same author

Bridging Tumor Growth Dynamics and Survival in Preclinical Oncology Drug Development - A Translational Tumor Growth Inhibition and Time to Event (TGI-TTE) Modeling Framework.

Research square·2026
Same author

Physiologically Based Pharmacokinetic Modeling to Predict Human Pharmacokinetics of a Novel Mithramycin Analog for Ewing Sarcoma.

Research square·2026
Same author

Does artificial intelligence need companionship to assist in drug discovery? The Kirsten rat sarcoma virus study.

BJR artificial intelligence·2026
Same author

Nonlinear Mixed-Effects Modeling to Characterize the Pharmacokinetics of a Novel Mithramycin Analogue for Ewing Sarcoma in Mice.

Research square·2026
Same author

Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signaling.

Science signaling·2025

Area of Science:

  • Biotechnology and Synthetic Biology
  • Enzyme Engineering
  • Natural Product Biosynthesis

Background:

  • Polyketide synthase (PKS) pathways are crucial for producing diverse natural products.
  • Post-PKS modifying enzymes significantly diversify PKS-derived compounds.
  • Understanding these enzymes is key to unlocking novel bioactive molecules.

Purpose of the Study:

  • To review the advancements in combinatorial biosynthesis for engineering post-PKS modifying enzymes.
  • To consolidate literature on enzymes like oxygenases, ketoreductases, and transferases.
  • To provide a foundation for future enzyme engineering efforts.

Main Methods:

  • Literature review of studies from 1985 to 2002.
  • Focus on combinatorial biosynthesis strategies.

Related Experiment Videos

  • Analysis of enzyme classes including oxygenases, ketoreductases, glycosyltransferases, methyltransferases, acyltransferases, halogenases, cyclases, and aminotransferases.

    • Main Results:

    • Demonstrated success of combinatorial biosynthesis in modifying enzyme function and specificity.
    • Highlighted the broad applicability across various enzyme classes.
    • Showcased the potential for generating novel compound structures.

    Conclusions:

    • Combinatorial biosynthesis is a powerful tool for enzyme engineering in natural product drug discovery.
    • Further exploration of these enzymes can lead to new therapeutic agents.
    • This review serves as a comprehensive resource for the field.